<DOC>
	<DOCNO>NCT01122264</DOCNO>
	<brief_summary>The purpose study investigate treatment erectile dysfunction long-acting drug ( Tadalafil ) take day take need result longer treatment adherence well long term outcome ( 24 week ) , compare short-acting drug ( Sildenafil Citrate ) take need .</brief_summary>
	<brief_title>A Study Patients With Erectile Dysfunction</brief_title>
	<detailed_description />
	<mesh_term>Erectile Dysfunction</mesh_term>
	<mesh_term>Sildenafil Citrate</mesh_term>
	<mesh_term>Tadalafil</mesh_term>
	<mesh_term>Citric Acid</mesh_term>
	<criteria>History Erectile Dysfunction ( ED ) least 3 month duration . Anticipate adult female sexual partner study . Agree use treatment ED participate recording response questionnaires instrument use study . Previous current treatment tadalafil phosphodiesterase type 5 ( PDE5 ) inhibitor . ED cause primary sexual disorder , history radical prostatectomy pelvic surgery subsequent failure achieve erection , history penile implant clinically significant penile deformity . ED cause untreated inadequately treated endocrine disease . Current treatment doxazosin , nitrate , cancer chemotherapy , antiandrogens . Severe renal hepatic impairment , history malignant hypertension . Presence history specific heart condition .</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2012</verification_date>
	<keyword>Erectile Dysfunction</keyword>
</DOC>